COVID-19-associated secondary sclerosing cholangitis – A case series of 4 patients

Clinics and Research in Hepatology and Gastroenterology(2022)

Cited 3|Views2
No score
Abstract
We report a case series of four patients diagnosed with COVID-19-associated second-ary sclerosing cholangitis (SSC), a recently described rare late complication of severe COVID-19. Following prolonged stays in the intensive care unit, these patients developed marked sustained cholestasis and jaundice despite clinical improvement. Cholangiography showed beaded appear-ance of intra-hepatic bile ducts and bile casts were removed in one patient. None of the patients reached normalization of liver enzymes and at least one progressed to liver cirrhosis (follow-up time of 11 to 16 months). COVID-19-associated SSC has a dismal prognosis with rapid progression to advanced chronic liver disease.(c) 2022 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
More
Translated text
Key words
COVID-19,Secondary sclerosing cholangitis,Cholangiopathy,Case series
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined